EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPKIG00000001778
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Proteasome Regulatory Subunit 4

Ensembl ID : ENSPKIG00000022845
Gene Symbol: LOC111841780
2 Cross references
274 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPKIG00000018702
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSPKIG00000024297
Gene Symbol: LOC111835705
3 Cross references
261 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSPKIG00000001937
Gene Symbol: LOC111833435
3 Cross references
221 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSPKIG00000001776
Gene Symbol: LOC111846388
3 Cross references
170 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSPKIG00000023021
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSPKIG00000009582
Gene Symbol: LOC111850194
4 Cross references
163 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSPKIG00000019412
Gene Symbol: LOC111850194
4 Cross references
46 Possible Orthologues:

40s Ribosomal Protein S15-Like

Ensembl ID : ENSPKIG00000007094
Gene Symbol: LOC111847656
3 Cross references
330 Possible Orthologues:

40s Ribosomal Protein S15a

Ensembl ID : ENSPKIG00000019847
Gene Symbol: LOC111849123
3 Cross references
116 Possible Orthologues:

40s Ribosomal Protein S16

Ensembl ID : ENSPKIG00000001864
Gene Symbol: LOC111843378
3 Cross references
312 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).